$SGMO
SANGAMO THERAPEUTICS, INC

2015 Q2 Form 10-Q Financial Statement

#000156459015006479 Filed on August 06, 2015

View on sec.gov

Income Statement

Concept 2015 Q2
Revenue $8.358M
YoY Change -19.52%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.020M
YoY Change 26.45%
% of Gross Profit
Research & Development $15.62M
YoY Change 16.03%
% of Gross Profit
Depreciation & Amortization $300.0K
YoY Change 50.0%
% of Gross Profit
Operating Expenses $20.64M
YoY Change 18.37%
Operating Profit
YoY Change
Interest Expense $150.0K
YoY Change 114.29%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$12.13M
YoY Change 73.78%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$12.13M
YoY Change 73.7%
Net Earnings / Revenue -145.08%
Basic Earnings Per Share
Diluted Earnings Per Share -$174.1K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $214.2M
YoY Change 10.58%
Cash & Equivalents $10.77M
Short-Term Investments $203.5M
Other Short-Term Assets $1.200M
YoY Change 78.84%
Inventory
Prepaid Expenses
Receivables $5.200M
Other Receivables $400.0K
Total Short-Term Assets $221.0M
YoY Change 8.88%
LONG-TERM ASSETS
Property, Plant & Equipment $3.200M
YoY Change 97.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.900M
YoY Change -90.87%
Other Assets $200.0K
YoY Change
Total Long-Term Assets $8.900M
YoY Change -81.4%
TOTAL ASSETS
Total Short-Term Assets $221.0M
Total Long-Term Assets $8.900M
Total Assets $229.9M
YoY Change -8.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.500M
YoY Change 66.67%
Accrued Expenses $2.000M
YoY Change 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $21.06M
YoY Change 25.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $8.900M
YoY Change -52.91%
Total Long-Term Liabilities $8.900M
YoY Change -52.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.06M
Total Long-Term Liabilities $8.900M
Total Liabilities $30.00M
YoY Change -17.76%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $199.9M
YoY Change
Total Liabilities & Shareholders Equity $229.9M
YoY Change -8.35%

Cashflow Statement

Concept 2015 Q2
OPERATING ACTIVITIES
Net Income -$12.13M
YoY Change 73.7%
Depreciation, Depletion And Amortization $300.0K
YoY Change 50.0%
Cash From Operating Activities -$8.000M
YoY Change -6.98%
INVESTING ACTIVITIES
Capital Expenditures -$1.000M
YoY Change 150.0%
Acquisitions
YoY Change
Other Investing Activities -$7.200M
YoY Change -64.71%
Cash From Investing Activities -$8.100M
YoY Change -61.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.700M
YoY Change 0.0%
NET CHANGE
Cash From Operating Activities -8.000M
Cash From Investing Activities -8.100M
Cash From Financing Activities 1.700M
Net Change In Cash -14.40M
YoY Change -48.01%
FREE CASH FLOW
Cash From Operating Activities -$8.000M
Capital Expenditures -$1.000M
Free Cash Flow -$7.000M
YoY Change -14.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
3948000
CY2014Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1870000
CY2014Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1800000
CY2014Q4 sgmo Escrow Liability
EscrowLiability
275000
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9524000
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
21056000
CY2015Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
8948000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
748000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7616000
us-gaap Operating Expenses
OperatingExpenses
33159000
us-gaap Revenue From Grants
RevenueFromGrants
1377000
us-gaap Revenue From Grants
RevenueFromGrants
1212000
us-gaap Revenues
Revenues
21849000
us-gaap Revenues
Revenues
18501000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25543000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
80000
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
1870000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-748000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-27000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3814000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1076000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1329000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1221000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
17164000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2805000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
67003000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
50604000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
465000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-16864000
sgmo Net Proceeds From Issuance Public Offering
NetProceedsFromIssuancePublicOffering
93796000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
48000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9347000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
84000
CY2015Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
13000
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
33000
CY2015Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
16000
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
58000
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
223374000
CY2014 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
700000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5836000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4036000

Files In Submission

Name View Source Status
0001564590-15-006479-index-headers.html Edgar Link pending
0001564590-15-006479-index.html Edgar Link pending
0001564590-15-006479.txt Edgar Link pending
0001564590-15-006479-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sgmo-10q_20150630.htm Edgar Link pending
sgmo-20150630.xml Edgar Link completed
sgmo-20150630.xsd Edgar Link pending
sgmo-20150630_cal.xml Edgar Link unprocessable
sgmo-20150630_def.xml Edgar Link unprocessable
sgmo-20150630_lab.xml Edgar Link unprocessable
sgmo-20150630_pre.xml Edgar Link unprocessable
sgmo-ex101_18.htm Edgar Link pending
sgmo-ex102_19.htm Edgar Link pending
sgmo-ex311_20.htm Edgar Link pending
sgmo-ex312_21.htm Edgar Link pending
sgmo-ex321_22.htm Edgar Link pending
Show.js Edgar Link pending